iShares Health Innovation Active ETF (BMED)
NYSEARCA: BMED · Real-Time Price · USD
28.08
+0.20 (0.72%)
May 22, 2026, 4:00 PM EDT - Market closed
BMED Holdings Information
BMED is an equity ETF with a total of 60 individual holdings. The top holdings are Johnson & Johnson stock at 8.07%, Gilead Sciences at 5.51%, BlackRock Cash Funds Treasury SL Agency at 4.87%, Edwards Lifesciences at 4.77%, and Merck & Co. at 4.20%.
Total Holdings
60
Top 10 Percentage
44.46%
Asset Class
Equity
ETF Category
Health
Assets
10.05M
PE Ratio
22.80
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 8.07% |
| 2 | GILD | Gilead Sciences, Inc. | 5.51% |
| 3 | XTSLA | BlackRock Cash Funds Treasury SL Agency | 4.87% |
| 4 | EW | Edwards Lifesciences Corporation | 4.77% |
| 5 | MRK | Merck & Co., Inc. | 4.20% |
| 6 | BIIB | Biogen Inc. | 3.74% |
| 7 | AMGN | Amgen Inc. | 3.51% |
| 8 | WAT | Waters Corporation | 3.50% |
| 9 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 3.25% |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | 3.04% |
| 11 | BRKR | Bruker Corporation | 2.76% |
| 12 | CRL | Charles River Laboratories International, Inc. | 2.76% |
| 13 | MRNA | Moderna, Inc. | 2.69% |
| 14 | MTD | Mettler-Toledo International Inc. | 2.61% |
| 15 | PFE | Pfizer Inc. | 2.45% |
| 16 | SWX: NOVN | Novartis AG | 2.41% |
| 17 | DXCM | DexCom, Inc. | 2.37% |
| 18 | DHR | Danaher Corporation | 2.37% |
| 19 | GSK | GSK plc | 2.03% |
| 20 | PTGX | Protagonist Therapeutics, Inc. | 2.03% |
| 21 | SWX: ROP | Roche Holding AG | 1.89% |
| 22 | TMO | Thermo Fisher Scientific Inc. | 1.85% |
| 23 | TECH | Bio-Techne Corporation | 1.76% |
| 24 | TEVA | Teva Pharmaceutical Industries Limited | 1.70% |
| 25 | LON: AZN | AstraZeneca PLC | 1.64% |
As of May 20, 2026